Boudreaux
- Additives
- Glycine
Mondae Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.7/10
Best for: choosing your own compounding pharmacy from a named list, at one flat price per dose
7.7
★★★★☆3.9/5
Price is where Mondae scores best in our breakdown.
Semaglutide
$115/mo
Tirzepatide
$145/mo
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
See plans →See plans at Mondae →
Compare top-rated alternatives ↓No insurance needed · Vetted by our editors
Mondae is a compounded GLP-1 telehealth platform run by Mondae LLC that lets you pick which pharmacy fills your prescription from a named list of six, and holds one price across every dose. Compounded semaglutide is $115 a month and compounded tirzepatide is $145 a month, billed monthly, with the same rate whether you choose the one or three-month plan. It also offers sermorelin, NAD+ and glutathione injections.
By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedSemaglutideTirzepatideNames its pharmacyChoose your pharmacyFlat price at every doseNo membership fees
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Mondae
★★★★☆4/5
Editorial score · methodology
$99/mosemaglutide
$199/motirzepatide
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript VerifiedFDA Warning
Get StartedRead full Strut Health review →★★★★☆3.9/5
Editorial score · methodology
$146/mosemaglutide
$258/motirzepatide
CompoundedSemaglutideTirzepatideNAD+Sermorelin
Get StartedRead full Yucca Health review →★★★★☆3.9/5
Editorial score · methodology
$149/mosemaglutide
$259/motirzepatide
CompoundedSemaglutideTirzepatide
Get StartedRead full TrimRx review →Mondae at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $115/mo
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Mondae
Each dimension is scored algorithmically from Mondae’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.7/10At $115/mo, Mondae runs about 32% below the $170 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.8/10Mondae offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.1/10Online intake and platform experience — consult included in the price; 7 platform features disclosed.
Trust & Safety15%
7.5/10Core details confirmed by our editors; no FDA warning letters on file; discloses which pharmacy makes its medication.
Accessibility10%
8.0/10Mondae treats patients in all 50 states.
Support10%
5.6/10Mondae provides standard clinician follow-up; no extended coaching or community program is disclosed.
6scored dimensions
616providers compared
100%verified against live provider sites
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Mondae review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Verified the compounding pharmacy partner and its accreditation
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $115–$145/mo across 2 dose/plan tiers — checked August 2026
- FDA warning-letter register
- No letter on file for this provider
- Compounding pharmacy partners
- Boudreaux, Rush, Hallandale, Greenwich, Align, VialsRx
What to expect when you sign up with Mondae
We walked Mondae’s public signup flow in August 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Treatment page shows the price, the full dose ladder and the pharmacy picker before any intake
- 2You select a starting dose, a pharmacy from six named options, and a 1 or 3-month plan length
- 3Get started routes through mondae.com/wlr, which redirects to the intake at go.mondae.com
- 4The intake is a timed questionnaire showing 3 mins left, then 2, then 1, then Last question
- 5It opens with your main weight-loss goal rather than asking for an account or payment
- 6Existing patients use a separate portal at my.mondae.com
Price shown before you start
- The pharmacy picker is the standout: six pharmacies named on the page, one of which (VialsRx) also appears on other providers we track
- Price genuinely does not move when you change dose or plan length, which we confirmed by toggling every option
- The intake asks a preference question first, so nothing personal is requested on the opening screen
- The struck-through $600 next to $115 is an anchor with no stated basis
GLP-1 medications Mondae offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Any dose .2mg-2.3mg (price fixed at every dose)Compounded
$115/mo
semaglutide
Same $115 whether the 1-month or 3-month plan is selected; a struck-through $600 is shown as an anchor price.
Any dose 1.5mg-13.5mg (price fixed at every dose)Compounded
$145/mo
tirzepatide
Same $145 on both the 1-month and 3-month plan.
Ready to get started?
Plans and promotions change often — check Mondae's current pricing and active discounts before you decide.
Mondae compounding-pharmacy partners
Each partner below is a 503A or 503B pharmacy that Mondae routes prescriptions through.
Rush
- Additives
- Glycine
Hallandale
- Additives
- Glycine
Greenwich
- Additives
- Glycine
Align
- Additives
- Glycine
VialsRx
- Additives
- Glycine
What we like
- Lets you choose which of six named pharmacies fills your prescription, which almost no competitor offers
- Discloses the compounding additive (glycine) on the product page, not buried in an FAQ
- One price at every dose: $115 semaglutide and $145 tirzepatide, with no dose-escalation surcharge
- Prices and the full dose ladder are published before any intake, with no membership fee
- Available in all 50 states through physicians licensed in your state of residence
Watch-outs
- Refunds are explicitly not guaranteed and the Terms state fees are not refundable in whole or in part
- Orders can only be canceled before the medication is dispensed or shipped
- The homepage advertises prices from $113 while the cheapest GLP-1 plan is actually $115
- A struck-through $600 is displayed next to the $115 price with no explanation of what $600 refers to
- The pharmacy that fills your order may change which additives are included
Is Mondae worth it?
The short version of what Mondae offers is choosing your own compounding pharmacy from a named list, at one flat price per dose. It runs $115/month, the same price at every dose, — toward the affordable end of the category, so cost isn't the reason to look elsewhere. Its flat, all-dose pricing is a genuine plus for anyone worried about cost climbing as they titrate up.
Mondae names the pharmacy that fills its prescriptions. It also charges the same price at every dose and charges no membership fee.
How much Mondae actually costs
Compounded semaglutide runs $115/month and compounded tirzepatide runs $145/month.
That puts Mondae below the roughly $170 median ongoing price across the GLP-1 providers we track — a real cost advantage.
For a direct comparison, Brightmeds runs semaglutide and tirzepatide from $100/month — worth pricing against Mondae before you commit.
Medications: what Mondae prescribes
Mondae prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two most-studied weight-loss molecules on the market today. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy — the reason the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
Who Mondae is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost — $115/month is below the roughly $170 median we track across the category.
- live anywhere in the US and want the certainty that your state is already covered.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
Mondae treats patients in all 50 states, and names the pharmacy that fills its prescriptions, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Mondae earns its place on the shortlist mainly on price: at $115/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
Price is where Mondae scores best in our breakdown.
Score: 7.7/10Best for: choosing your own compounding pharmacy from a named list, at one flat price per doseFrom: $115/mo
Ready to start with Mondae?
Starting at $115/month. See current pricing and start your free consultation.
Mondae might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider MEDVi.
Frequently Asked Questions
Mondae is a compounded GLP-1 telehealth platform run by Mondae LLC that lets you pick which pharmacy fills your prescription from a named list of six, and holds one price across every dose. Compounded semaglutide is $115 a month and compounded tirzepatide is $145 a month, billed monthly, with the same rate whether you choose the one or three-month plan. It also offers sermorelin, NAD+ and glutathione injections. We scored it 7.7/10 across our six-dimension editorial framework.
Yes — Mondae is a legitimate telehealth provider. Our editors independently verified its pricing and offering and scored it 7.7/10 across our six-dimension framework. As with any medication, consult a licensed clinician before starting.
Mondae starts at $115/month. The price is flat across doses, so it doesn't increase as you titrate up. See the pricing table above for every tier.
Mondae doesn't use public promo or coupon codes — its $115/month is an all-inclusive cash price with no insurance or coupons needed. Third-party sites advertising "Mondae discount codes" are typically fake; any current offer applies automatically through the link on this page.
Mondae treats patients in all 50 states.
Mondae offers semaglutide (the active drug in Wegovy/Ozempic) and tirzepatide (the active drug in Zepbound/Mounjaro). These are dispensed as compounded formulations.
Mondae dispenses compounded GLP-1s made by a licensed compounding pharmacy — the same active ingredient as the brand drugs at a lower cash price. Compounded drugs are not FDA-approved as finished products; we cover what that means in the review.
Mondae is a cash-pay program — no insurance is required, which is why the monthly price is transparent up front.
Mondae's price includes medication, the clinician consult and shipping. See the "what's included" strip near the top of this review.
You complete an online intake, a licensed clinician reviews whether a GLP-1 is appropriate for you, and — if approved — your medication ships to your door. You can begin the consultation directly on Mondae's site.
We don't find any safety warnings on file (no FDA action). The concerns our review flags are mostly transparency-related: Refunds are explicitly not guaranteed and the Terms state fees are not refundable in whole or in part; Orders can only be canceled before the medication is dispensed or shipped; The homepage advertises prices from $113 while the cheapest GLP-1 plan is actually $115; A struck-through $600 is displayed next to the $115 price with no explanation of what $600 refers to. None are safety issues, but they're worth weighing before you sign up.
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Mondae review:
Sources & methodology — as of September 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Mondae's current pricing
Plans start at $115/month. Start your free consultation to check eligibility and today's price.
Not sold on Mondae?
Vetted alternatives